Utah Historical Balance Sheet

UTMD Stock

USD 59.71 0.29 0.48%

Trend analysis of Utah Medical Products balance sheet accounts such as Total Assets of 163.6 M, Short Long Term Debt Total of 322.3 K, Other Current Liabilities of 2.6 M or Total Current Liabilities of 4.6 M provides information on Utah Medical's total assets, liabilities, and equity, which is the actual value of Utah Medical Products to its prevalent stockholders. By breaking down trends over time using Utah Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Utah Medical Products latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Utah Medical Products is a good buy for the upcoming year.

Utah Medical Inventory

11.57 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Utah Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Utah Medical Products at a specified time, usually calculated after every quarter, six months, or one year. Utah Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Utah Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Utah currently owns. An asset can also be divided into two categories, current and non-current.

Utah Medical Balance Sheet Chart

At present, Utah Medical's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Retained Earnings is expected to grow to about 167 M, whereas Other Current Liabilities is forecasted to decline to about 2.6 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Utah Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Utah Medical Products books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Utah Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Utah Medical Products are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Utah Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Utah Medical Products current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	341K	295K	339.3K	322.3K
Total Assets	123.9M	135.5M	155.8M	163.6M

Short Long Term Debt Total Total Assets

Utah Medical balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock Total Equity	Common Stock
Total Assets		-0.33	0.55	0.04	0.98	0.8	-0.85	0.97	0.91	0.05	0.0	0.91	0.49	-0.59	-0.24	0.96	-0.08	-0.76	-0.18	0.85	0.93	-0.36	-0.22	-0.38	-0.78	-0.78
Short Long Term Debt Total	-0.33		-0.32	0.78	-0.51	-0.24	0.7	-0.53	-0.54	0.53	-0.06	-0.54	0.19	-0.1	0.95	-0.31	0.53	0.17	0.95	-0.36	-0.52	0.69	0.08	0.93	-0.05	-0.05
Other Current Liab	0.55	-0.32		-0.17	0.56	0.66	-0.66	0.6	0.63	-0.22	0.07	0.63	0.09	-0.28	-0.2	0.56	-0.52	-0.69	-0.2	0.52	0.62	-0.53	-0.59	-0.53	-0.32	-0.32
Total Current Liabilities	0.04	0.78	-0.17		-0.15	0.11	0.38	-0.18	-0.24	0.66	-0.04	-0.24	0.5	-0.48	0.78	0.0	0.67	-0.06	0.88	-0.12	-0.21	0.67	0.36	0.85	-0.44	-0.44
Total Stockholder Equity	0.98	-0.51	0.56	-0.15		0.75	-0.92	1.0	0.96	-0.09	0.01	0.96	0.38	-0.49	-0.44	0.95	-0.2	-0.71	-0.38	0.87	0.97	-0.5	-0.23	-0.54	-0.68	-0.68
Property Plant And Equipment Net	0.8	-0.24	0.66	0.11	0.75		-0.64	0.77	0.61	0.38	0.0	0.61	0.5	-0.82	-0.07	0.67	0.02	-0.92	-0.02	0.52	0.63	-0.09	-0.31	-0.32	-0.83	-0.83
Net Debt	-0.85	0.7	-0.66	0.38	-0.92	-0.64		-0.93	-0.96	0.37	0.0	-0.96	-0.15	0.28	0.66	-0.85	0.43	0.59	0.61	-0.85	-0.95	0.73	0.34	0.74	0.42	0.42
Retained Earnings	0.97	-0.53	0.6	-0.18	1.0	0.77	-0.93		0.95	-0.1	0.03	0.95	0.37	-0.49	-0.44	0.94	-0.21	-0.75	-0.39	0.86	0.96	-0.51	-0.27	-0.57	-0.68	-0.68
Cash	0.91	-0.54	0.63	-0.24	0.96	0.61	-0.96	0.95		-0.35	-0.02	1.0	0.18	-0.27	-0.51	0.95	-0.37	-0.58	-0.46	0.92	1.0	-0.69	-0.34	-0.6	-0.49	-0.49
Non Current Assets Total	0.05	0.53	-0.22	0.66	-0.09	0.38	0.37	-0.1	-0.35		0.04	-0.35	0.65	-0.74	0.65	-0.12	0.71	-0.34	0.69	-0.33	-0.31	0.86	0.3	0.55	-0.6	-0.6
Non Currrent Assets Other	0.0	-0.06	0.07	-0.04	0.01	0.0	0.0	0.03	-0.02	0.04		-0.02	0.08	-0.02	-0.04	0.01	0.0	-0.11	-0.04	-0.08	-0.02	0.08	-0.02	-0.07	0.01	0.01
Cash And Short Term Investments	0.91	-0.54	0.63	-0.24	0.96	0.61	-0.96	0.95	1.0	-0.35	-0.02		0.18	-0.27	-0.51	0.95	-0.37	-0.58	-0.46	0.92	1.0	-0.69	-0.34	-0.6	-0.49	-0.49
Net Receivables	0.49	0.19	0.09	0.5	0.38	0.5	-0.15	0.37	0.18	0.65	0.08	0.18		-0.72	0.3	0.37	0.46	-0.51	0.37	0.28	0.23	0.39	0.26	0.2	-0.72	-0.72
Common Stock Shares Outstanding	-0.59	-0.1	-0.28	-0.48	-0.49	-0.82	0.28	-0.49	-0.27	-0.74	-0.02	-0.27	-0.72		-0.25	-0.42	-0.55	0.75	-0.33	-0.24	-0.3	-0.41	-0.11	-0.09	0.93	0.93
Non Current Liabilities Total	-0.24	0.95	-0.2	0.78	-0.44	-0.07	0.66	-0.44	-0.51	0.65	-0.04	-0.51	0.3	-0.25		-0.28	0.52	0.0	0.98	-0.37	-0.48	0.73	0.06	0.85	-0.2	-0.2
Inventory	0.96	-0.31	0.56	0.0	0.95	0.67	-0.85	0.94	0.95	-0.12	0.01	0.95	0.37	-0.42	-0.28		-0.16	-0.65	-0.21	0.91	0.96	-0.49	-0.26	-0.37	-0.65	-0.65
Other Current Assets	-0.08	0.53	-0.52	0.67	-0.2	0.02	0.43	-0.21	-0.37	0.71	0.0	-0.37	0.46	-0.55	0.52	-0.16		-0.02	0.59	-0.24	-0.34	0.81	0.52	0.63	-0.45	-0.45
Other Stockholder Equity	-0.76	0.17	-0.69	-0.06	-0.71	-0.92	0.59	-0.75	-0.58	-0.34	-0.11	-0.58	-0.51	0.75	0.0	-0.65	-0.02		-0.02	-0.48	-0.6	0.07	0.43	0.33	0.8	0.8
Total Liab	-0.18	0.95	-0.2	0.88	-0.38	-0.02	0.61	-0.39	-0.46	0.69	-0.04	-0.46	0.37	-0.33	0.98	-0.21	0.59	-0.02		-0.32	-0.43	0.75	0.15	0.89	-0.28	-0.28
Property Plant And Equipment Gross	0.85	-0.36	0.52	-0.12	0.87	0.52	-0.85	0.86	0.92	-0.33	-0.08	0.92	0.28	-0.24	-0.37	0.91	-0.24	-0.48	-0.32		0.93	-0.64	-0.32	-0.42	-0.45	-0.45
Total Current Assets	0.93	-0.52	0.62	-0.21	0.97	0.63	-0.95	0.96	1.0	-0.31	-0.02	1.0	0.23	-0.3	-0.48	0.96	-0.34	-0.6	-0.43	0.93		-0.66	-0.32	-0.57	-0.52	-0.52
Intangible Assets	-0.36	0.69	-0.53	0.67	-0.5	-0.09	0.73	-0.51	-0.69	0.86	0.08	-0.69	0.39	-0.41	0.73	-0.49	0.81	0.07	0.75	-0.64	-0.66		0.49	0.75	-0.25	-0.25
Accounts Payable	-0.22	0.08	-0.59	0.36	-0.23	-0.31	0.34	-0.27	-0.34	0.3	-0.02	-0.34	0.26	-0.11	0.06	-0.26	0.52	0.43	0.15	-0.32	-0.32	0.49		0.34	-0.06	-0.06
Short Term Debt	-0.38	0.93	-0.53	0.85	-0.54	-0.32	0.74	-0.57	-0.6	0.55	-0.07	-0.6	0.2	-0.09	0.85	-0.37	0.63	0.33	0.89	-0.42	-0.57	0.75	0.34		-0.02	-0.02
Common Stock Total Equity	-0.78	-0.05	-0.32	-0.44	-0.68	-0.83	0.42	-0.68	-0.49	-0.6	0.01	-0.49	-0.72	0.93	-0.2	-0.65	-0.45	0.8	-0.28	-0.45	-0.52	-0.25	-0.06	-0.02		1.0
Common Stock	-0.78	-0.05	-0.32	-0.44	-0.68	-0.83	0.42	-0.68	-0.49	-0.6	0.01	-0.49	-0.72	0.93	-0.2	-0.65	-0.45	0.8	-0.28	-0.45	-0.52	-0.25	-0.06	-0.02	1.0

Click cells to compare fundamentals

Utah Medical Account Relationship Matchups

Utah Medical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	111.7M	115.6M	123.9M	135.5M	155.8M	163.6M
Short Long Term Debt Total	335K	331K	341K	295K	339.3K	322.3K
Other Current Liab	2.9M	2.7M	4.3M	3.6M	4.2M	2.6M
Total Current Liabilities	3.8M	3.6M	5.8M	4.7M	5.4M	4.6M
Total Stockholder Equity	102.8M	107.1M	114.3M	128.3M	147.6M	154.9M
Property Plant And Equipment Net	11.3M	11.0M	10.6M	10.6M	12.1M	9.6M
Net Debt	(51.3M)	(60.6M)	(74.7M)	(92.6M)	(83.3M)	(79.1M)
Retained Earnings	111.0M	115.3M	126.0M	138.3M	159.1M	167.0M
Cash	51.6M	61.0M	75.1M	92.9M	106.8M	112.1M
Non Current Assets Total	49.5M	42.4M	34.0M	29.2M	33.6M	27.1M
Non Currrent Assets Other	(49.5M)	(2.1M)	(1.5M)	(1.0)	(1.15)	(1.09)
Cash And Short Term Investments	51.6M	61.0M	75.1M	92.9M	106.8M	112.1M
Net Receivables	4.1M	5.1M	5.5M	3.3M	3.8M	4.5M
Common Stock Shares Outstanding	3.7M	3.7M	3.6M	3.6M	3.3M	5.0M
Liabilities And Stockholders Equity	111.7M	115.6M	123.9M	135.5M	155.8M	163.6M
Non Current Liabilities Total	5.1M	4.8M	3.9M	2.4M	2.8M	5.2M
Inventory	6.2M	6.6M	8.8M	9.6M	11.0M	11.6M
Other Current Assets	346K	456K	515K	481K	432.9K	411.3K
Other Stockholder Equity	115K	841K	251K	594.0K	534.6K	507.9K
Total Liab	8.9M	8.4M	9.6M	7.1M	8.2M	9.7M
Property Plant And Equipment Gross	11.3M	33.9M	33.2M	34.3M	39.4M	41.4M
Total Current Assets	62.3M	73.2M	89.9M	106.3M	122.2M	128.3M
Accumulated Other Comprehensive Income	(8.3M)	(9.1M)	(12.0M)	(10.7M)	(9.6M)	(9.1M)
Intangible Assets	24.0M	17.3M	10.4M	4.9M	5.7M	5.4M
Accounts Payable	788K	761K	1.2M	769K	884.4K	1.3M
Short Term Debt	41K	52K	54K	47K	54.1K	51.3K
Property Plant Equipment	10.7M	11.3M	11.0M	10.2M	11.8M	10.1M
Good Will	14.2M	14.1M	13.4M	13.7M	15.7M	13.0M
Current Deferred Revenue	(41K)	(52K)	(54K)	327K	294.3K	232.6K
Other Liab	4.9M	4.8M	4.5M	3.3M	3.8M	4.9M
Net Tangible Assets	56.9M	64.7M	75.7M	90.5M	104.1M	62.4M
Retained Earnings Total Equity	110.8M	111.0M	115.3M	126.0M	144.9M	93.3M
Capital Surpluse	18K	115K	841K	251K	225.9K	214.6K
Deferred Long Term Liab	521K	651K	577K	549K	494.1K	356.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:

How To Invest In Utah

Details

Is Utah Stock a good investment?

Details

What is Utah Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.27)

Dividend Share

1.205

Earnings Share

3.96

Revenue Per Share

11.677

Quarterly Revenue Growth

(0.26)

The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Utah Historical Balance Sheet

Utah Medical Inventory

11.57 Million

About Utah Balance Sheet Analysis

Utah Medical Balance Sheet Chart

Total Assets

Total Current Liabilities

Utah Medical balance sheet Correlations

Utah Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Utah Medical balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Total Stockholder Equity	+ 0.98	Total Assets

Cash And Short Term Investments	- 0.96	Net Debt
Cash	- 0.96	Net Debt
Total Current Assets	- 0.95	Net Debt
Retained Earnings	- 0.93	Net Debt
Other Stockholder Equity	- 0.92	Property Plant And Equipment Net
Net Debt	- 0.92	Total Stockholder Equity